Last reviewed · How we verify
NCT06624033: LEG'UP
Bioavailability of Legume Proteins in Differents Products
NA trial testing amino acids kinetics in Healthy in 12 participants. Completed in 22 September 2023.
22 September 2022
Quick facts
| Lead sponsor | Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 12 |
| Start date | 22 June 2020 |
| Primary completion | 22 September 2022 |
| Estimated completion | 22 September 2023 |
| Sites | 1 location across France |
Drugs / interventions tested
- amino acids kinetics
Conditions studied
Sponsor
Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement
Who can join
Adults 18 to 29, male only, with Healthy or Men. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The use of pea proteins could be interesting in specific foods. Indeed, these proteins could have great nutritional quality, with good amino acid profile. Therefore, the investigators study the bioavailability of protein and post-prandial variation of metabolic markers following consumption of pea protein-enriched products in healthy young subjects. Main Objective is to compare plasma kinetics of leucine.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06624033
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Healthy
Currently open trials in the same condition.
- NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
- NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
- NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
- NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
- NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting
Other Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement trials
Trials by the same sponsor.
- NCT07521189 — Effect of Vegetarien Diet on Protein Digestibility in Young and Elderly Volunteers · NA · recruiting
- NCT07212400 — Collection of Stool From Healthy Donors for the ex Vivo Study of Shifts of Microbiome Induced by Dairy Phages and Antibi · recruiting
- NCT07162025 — Improving Nutrition for Babies Born by Caesarean Section · recruiting
- NCT06174233 — The French Gut-colo · recruiting
- NCT06436937 — Protein Quality of Fava Bean and Honey Chlorella in Humans · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06624033 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement
- Last refreshed: 2 October 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06624033.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing